Backed by Marquee Investors - Kedaara Capital, Goldman Sachs, ICICI Prudential Life Insurance, ACM Global
Recent Equity Raise & Strong Capitalisation: Shareholders have recently approved a ₹400 Crs equity infusion which will further improve its CRAR to 35%+, well above the RBI’s 15% minimum requirement signalling ample headroom for growth.
Strong liquidity: As on Dec'25, Spandana had Cash balance of ₹1,626 Crs. in the from of Mutual Funds, FDs which was 26.61% of its asset base, underscoring a strong liquidity buffer)










